Sub Banner Image

Novo Investors Eye Alzheimer’s Trial for Glimmer of Hope

Markets

Lisa Pham

·

October 1, 2025

·

Bloomberg

After another dismal quarter for Novo Nordisk A/S shares, investors are looking to an experimental treatment of the most common form of dementia to help spark a revival.

More from

Bloomberg

More

Markets

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.